Sickle Cell Disease Association of America Inc
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$2,250,168
Cash & Equivalents
49%
Investments
26%
Receivables (Non-Related)
21%
Other Assets
3%
Property, Plant, & Equipment (net)
<1%
Inventories
<1%
Prepaid Expenses
<1%
Related-Party Receivables
0%
Liabilities in 2024 (Year End)
$423,888
Deferred Revenue
59%
Notes Payable / Debt (Non-Related)
24%
Other Liabilities
17%
Payables & Accruals
0%
Grants Payable
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$1,207,162
$1,103,200
-9%
Receivables (Non-Related)
$363,870
$461,901
+27%
Related-Party Receivables
-
-
-
Inventories
$4,213
$4,213
+0%
Prepaid Expenses
$4,867
$4,200
-14%
Investments
$580,206
$580,206
+0%
Property, Plant, & Equipment (net)
$20,316
$20,316
+0%
Other Assets
$76,132
$76,132
+0%
Total Assets
$2,256,766
$2,250,168
0%
Liabilities
2023
2024
Change
Payables & Accruals
$91,636
-
-
Grants Payable
-
-
-
Deferred Revenue
$250,000
$250,000
+0%
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
$105,542
$102,300
-3%
Related-Party Payables
-
-
-
Other Liabilities
$71,558
$71,588
+0%
Total Liabilities
$518,736
$423,888
-18%
Net assets
2023
2024
Change
Restricted Net Assets
$15,000
$15,000
+0%
Unrestricted Net Assets
$1,723,030
$1,811,280
+5%
Net assets
2023
2024
Change
Net assets
+$1,738,030
+$1,826,280
+5%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)